Upon tissue damage and infection, a functional immune system recruits leukocytes through a process called chemotaxis that involves chemokines signaling through chemokine receptors. Chemokine binding and subsequent signaling is dependent on a two-site binding model with cognate chemokine G-protein coupled receptors (GPCRs). However, the dysregulated recruitment of these chemokines plays a significant role in the pathology of various inflammatory and autoimmune diseases. As such, chemokines and their receptors serve as valuable therapeutic targets for the modulation of these disease pathways.
A significant step in the binding of chemokines with cognate receptors is the electrostatic interaction of an electropositive patch on chemokine proteins with N-terminal sulfated tyrosine (sTyr) residues on receptors, which provides an increase in binding affinity. 1, 2 This interaction is crucial for activity, such that it served as an evolutionary target for protein biomimicry by hematophagous organisms to inhibit the host immune response whilst obtaining a blood meal. 3-5 An example of this is the evasin family, salivary proteins derived from ticks, that utilize N-terminal sTyr to bind to chemokine proteins in order to inhibit cognate receptor binding and hence downstream immune signaling through chemokine receptor mimicry. 6-8
These sulfated biomolecules are privileged starting points for the development of effective therapeutics against inflammatory and autoimmune disease as evolution has adapted them for successful modulation of host defenses. 4 As such, a reliable understanding of their binding and interaction with chemokines is essential. These first steps were recently explored via the semi synthesis of full-length evasin protein, ACA-01, 3, 9, 10 which provided essential structure-activity data. 11 In this presentation, we will further explore this by utilizing solid-phase peptide synthesis (SPPS) to synthesize N-terminal sTyr peptides derived from evasin proteins in order to further uncover novel and modulated binding of chemokine proteins.